Intraocular Melanoma Treatment Market Industry Insights, Potential Revenue, and Top Players- Astra Zeneca, Eli Lilly & Co., Pfizer, Novartis AG, and Spectrum Pharmaceuticals

Coherent Market Insights has announced the addition of the “Intraocular Melanoma Treatment Market Size Status and Forecast 2026”, The report classifies the global Intraocular Melanoma Treatment Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth.

This report studies the global Intraocular Melanoma Treatment Speaker market, analyzes and researches the Intraocular Melanoma Treatment Speaker development status and forecast in North America, Europe, Asia Pacific, Latin America and Rest of the World. This report focuses on the top players in global market, like Astra Zeneca, Eli Lilly & Co., Pfizer, Novartis AG, and Spectrum Pharmaceuticals

Request a sample copy : https://www.coherentmarketinsights.com/insight/request-sample/1854

Intraocular (uveal) melanoma is a rare eye cancer, characterized with blurred vision or a dark spot on the iris. Various treatment options are available for intraocular melanoma, such as eye examinations. According to the National Cancer Institute (NCI), the standard treatments include surgery, radiation therapy, photocoagulation, and thermotherapy. Along with these standard treatments, some other treatments are also being tested in clinical trials. For instance, Nivolumab: an immunotherapy drugs shown to help people suffering from uveal melanoma by increasing patient’s overall immunity, are presently in Phase II clinical study. Additionally, other similar drugs being studied for uveal melanoma include combination of Ipilimumab and Nivolumab, and Selumetinib. Selumetinib is a targeted drug known to slow down the growth of eye melanoma, while nivolumab in combination with lpilimumab are being studied to control uveal melanoma are present in Phase II clinical study.

Moreover, according to American Society of Clinical Oncology (ASCO), individuals belonging to Caucasian race, people with light eye color and fair skin, or any individual and any of their family member having history of suffering from dysplastic nevus syndrome, seem to have a higher risk of developing intraocular melanoma. Moreover, over-exposure to sunlight, a known risk factor for melanoma of the skin, is also a risk factor for intraocular melanoma. These factors in turn, are expected to boost growth of the intraocular melanoma treatment market in the near future.

Intraocular Melanoma Treatment Market Drivers

Advancements in developing innovative treatment options in intraocular melanoma treatments such as understanding the molecular characteristics of intraocular tumor through genetic alternations and mutations studies in patients and novel therapies based on inhibition mechanism of expression of growth factor receptors such as c-Met and c-Kit, are being investigated to bring better treatment options for patients.

Moreover, rampant research pertaining to melanoma, increasing incidence burden of intraocular melanoma, and increasing number of clinical trials for new treatments, in turn, are expected to boost growth of the intraocular melanoma treatment market size over the forecasted period. According to the American Academy of Ophthalmology (AAO), 2014 data findings, uveal melanoma is the most commonly diagnosed primary intraocular malignancy in adults, with 90% of uveal melanoma involving the choroid, 5% affecting the ciliary body, and 5% developing in the iris. Additionally, uveal melanoma accounts for 5%-10% of all melanomas. Additionally, according to the American Academy of Ophthalmology (AAO), 2014 data findings, incidence of intraocular melanoma is higher among the fairly pigmented groups while exceedingly lower among Asian and African population.

Intraocular Melanoma Treatment Market Taxonomy

By Treatment

Targeted Therapy
Rituximab (Rituxan)
Ibritumomab (Zevalin)
Imatinib (Gleevec)
Sorafenib (Nexavar)
Other Therapies

By End User:

Hospitals
Specialty Clinics
Ambulatory Surgical Centers

Else place an Inquire before Purchase “Intraocular Melanoma Treatment Market
Size, Status and Forecast 2026 : https://www.coherentmarketinsights.com/insight/talk-to-analyst/1854

North America accounted for the major market share in 2017 and is expected to show lucrative growth opportunities in the near future, owing to increasing engagement of various government and private organizations in developing effective treatment options and rising incidence of intraocular melanoma in the region.

What Information does this report contain?

-Historical data coverage: 2013 to 2017; Growth Projections: 2018 to 2026.
-Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
-6-7 year performance forecasts: major segments covering applications, top products and geographies.
-Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.